Rights and permissions
About this article
Cite this article
Early epoetin alfa therapy may enhance QOL in NSCLC. Pharmacoecon. Outcomes News 428, 10 (2003). https://doi.org/10.1007/BF03276734
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03276734